Lymphedema

Current Treatment Options in Cardiovascular Medicine

Volumn 8, Issue 2, 2006, Pages 129-136

  Rockson, Stanley G ^a  

^a STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COUMARIN;

BANDAGING TECHNIQUE; COMPRESSION THERAPY; CYTOREDUCTIVE SURGERY; EXERCISE; HUMAN; INTERMITTENT PNEUMATIC COMPRESSION DEVICE; LIPOSUCTION; LIVER DYSFUNCTION; LOW LEVEL LASER THERAPY; LYMPHATIC DRAINAGE; LYMPHEDEMA; REVIEW; SKIN CARE;

EID: 33645574044     PISSN: 10928464     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11936-006-0005-y     Document Type: Review

References (49)

1. Rockson SG: Addressing the unmet needs in lymphoma risk management. Lymphat Res Biol 2006, in press.
2. Rockson S: Primary lymphedema. In Current Therapy in Vascular Surgery, edn 4. Edited by Ernst C, Stanley J. Philadelphia: Mosby; 2000:915-918.
3. Kinmonth J, ed: The Lymphatics, edn 2. London: Arnold Publishers; 1982.
4. Wolfe JHN, Kinmonth JB: The prognosis of primary lymphedema of the lower limbs. Arch Surg 1981, 116:1157-1160.
5. Szuba A, Rockson SG: Lymphedema: classification, diagnosis and therapy. Vasc Med 1998, 3:145-156.
6. Rockson SG: Lymphedema. Am J Med 2001, 110:288-295.
7. Milroy W: An undescribed variety of hereditary oedema. N Y Med J 1892, 56:505-508.
8. Irrthum A, Karkkainen MJ, Devriendt K, et al.: Congenital hereditary lymphedema caused by a mutation that inactivates VEGFR3 tyrosine kinase. Am J Hum Genet 2000, 67:295-301.
9. Karkkainen MJ, Ferrell RE, Lawrence EC, et al.: Missense mutations interfere with VEGFR-3 signalling in primary lymphoedema. Nat Genet 2000, 25:153-159.
10. Karkkainen MJ, Petrova TV: Vascular endothelial growth factor receptors in the regulation of angiogenesis and lymphangiogenesis. Oncogene 2000, 19:5598-5605.
11. Smeltzer DM, Stickler GB, Schirger A: Primary lymphedema in children and adolescents: a follow-up study and review. Pediatrics 1985, 76:206-218.
12. Fang J, Dagenais SL, Erickson RP, et al.: Mutations in FOXC2 (MFH-1), a forkhead family transcription factor, are responsible for the hereditary lymphedema-distichiasis syndrome. Am J Hum Genet 2000, 67:1382-1388.
13. Petrova TV, Karpanen T, Norrmen C, et al.: Defective valves and abnormal mural cell recruitment underlie lymphatic vascular failure in lymphedema distichiasis. Nat Med 2004, 10:974-981.
14. Irrthum A, Devriendt K, Chitayat D, et al.: Mutations in the transcription factor gene SOX18 underlie recessive and dominant forms of hypotrichosis-lymphedema-telangiectasia. Am J Hum Genet 2003, 72:1470-1478.
15. Bull LN, Roche E, Song EJ, et al.: Mapping of the locus for cholestasis-lymphedema syndrome (Aagenaes syndrome) to a 6.6-cM interval on chromosome 15q. Am J Hum Genet 2000, 67:994-999.
16. Rockson S: Syndromic lymphedema: keys to the kingdom of lymphatic structure and function? Lymphat Res Biol 2003, 1:181-183.
17. Michael E, Bundy DA, Grenfell BT: Re-assessing the global prevalence and distribution of lymphatic filariasis. Parasitology 1996, 112(Pt 4):409-428.
18. Bockarie M, Tisch D, Kastens W, et al.: Mass treatment to eliminate filariasis in Papua New Guinea. N Engl J Med 2002, 347:1841-1848.
19. Schirger A: Lymphedema. Cardiovasc Clin 1983, 13:293-305.
20. Szuba A, Rockson S: Lymphedema: a review of diagnostic techniques and therapeutic options. Vasc Med 1998, 3:145-156.
21. Rockson SG: Precipitating factors in lymphedema: myths and realities. Cancer 1998, 83(12 suppl American):2814-2816.
22. Herd-Smith A, Russo A, Muraca MG, et al.: Prognostic factors for lymphedema after primary treatment of breast carcinoma. Cancer 2001, 92:1783-1787.
23. Moffatt CJ, Franks PJ, Doherty DC, et al.: Lymphoedema: an underestimated health problem. QJM 2003, 96:731-738.
24. Petrek JA, Heelan MC: Incidence of breast carcinoma-related lymphedema. Cancer 1998, 83(12 suppl American):2776-2781.
25. Tengrup I, Tennvall-Nittby L, Christiansson I, Laurin M: Arm morbidity after breast-conserving therapy for breast cancer. Acta Oncol 2000, 39:393-397.
26. Werngren-Elgstrom M, Lidman D: Lymphoedema of the lower extremities after surgery and radiotherapy for cancer of the cervix. Scand J Plast Reconstr Surg Hand Surg 1994, 28:289-293.
27. Fiorica JV, Roberts WS, Greenberg H, et al.: Morbidity and survival patterns in patients after radical hysterectomy and postoperative adjuvant pelvic radiotherapy. Gynecol Oncol 1990, 36:343-347.
28. Soisson AP, Soper JT, Clarke-Pearson DL, et al.: Adjuvant radiotherapy following radical hysterectomy for patients with stage IB and IIA cervical cancer. Gynecol Oncol 1990, 37:390-395.
29. Starritt EC, Joseph D, McKinnon JG, et al.: Lymphedema after complete axillary node dissection for melanoma assessment using a new, objective definition. Ann Surg 2004, 240:866-874.
30. Merli G: Lymphedema. Clin Podiatry 1984, 1:363-372.
31. Kyle VM, De Silva M, Hurst G: Rheumatoid lymphoedema. Clin Rheumatol 1982, 1:126.
32. Lynde C, Mitchell I: Unusual complication of allergic contact dermatitis of the hands - recurrent lymphangitis and persistent lymphoedema. Contact Dermatitis 1982, 8:279-280.
33. Reed B, Burke S, Bozeman M, et al.: Lymphedema of the lower abdominal wall in pregnancy. J Am Acad Dermatol 1985, 12:930-932.
34. Szuba A, Shin WS, Strauss HW, Rockson S: The third circulation: radionuclide lymphoscintigraphy in the evaluation of lymphedema. J Nucl Med 2003, 44:43-57.
35. Szuba A, Strauss H, Sirsikar S, Rockson S: Quantitative radionuclide lymphoscintigraphy predicts outcome of manual breast cancer-related lymphedema of the upper extremity. Nucl Med Commun 2002, 23:1171-1175.
36. Scanlon EF: James Ewing lecture. The process of metastasis. Cancer 1985, 55:1163-1166.
37. Casley-Smith JR, Morgan RG, Piller NB: Treatment of lymphedema of the arms and legs with 5,6-benzo-[alpha]-pyrone. N Engl J Med 1993, 329:1158-1163.
38. Campisi C, Boccardo F: Microsurgical techniques for lymphedema treatment: derivative lymphatic-venous microsurgery. World J Surg 2004, 28:609-613.
39. Nagase T, Gonda K, Inoue V, et al.: Treatment of lymphedema with lymphaticovenular anastomoses. Int J Clin Oncol 2005, 10:304-310.
40. Brorson H: Liposuction in arm lymphedema treatment. Scand J Surg 2003, 92:287-295.
41. Bagheri S, Ohlin K, Olsson G, Brorson H: Tissue tonometry before and after liposuction of arm lymphedema following breast cancer. Lymphat Res Biol 2005, 3:66-80.
42. Classen DA, Irvine L: Free muscle flap transfer as a lymphatic bridge for upper extremity lymphedema. J Reconstr Microsurg 2005, 21:93-99.
43. Szuba A, Cooke JP, Yousuf S, Rockson SG: Decongestive lymphatic therapy for patients with cancer-related or primary lymphedema. Am J Med 2000, 109:296-300.
44. Rockson SG, Miller LT, Senie R, et al.: American Cancer Society Lymphedema Workshop. Workgroup III: diagnosis and management of lymphedema. Cancer 1998, 83 (12 suppl American):2882-2885.
45. Szuba A, Achalu R, Rockson SG: Decongestive lymphatic therapy for patients with breast carcinoma-associated lymphedema. A randomized, prospective study of a role for adjunctive intermittent pneumatic compression. Cancer 2002, 95:2260-2267.
46. Szuba A, Razavi M, Rockson SG: Diagnosis and treatment of concomitant venous obstruction in patients with secondary lymphedema. J Vasc Interv Radiol 2002, 13:799-803.
47. Piller NB, Thelander A: Treatment of chronic postmastectomy lymphedema with low level laser therapy: a 2.5 year follow-up. Lymphology 1998, 31:74-86.
48. Carati CJ, Anderson SN, Gannon BJ, Piller NB: Treatment of postmastectomy lymphedema with low-level laser therapy: a double-blind, placebo-controlled trial. Cancer 2003, 98:1114-1122.
49. Ogawa Y, Yoshizumi M, Kitagawa T, et al.: Investigation of the mechanism of lymphocyte injection therapy in treatment of lymphedema with special emphasis on cell adhesion molecule (L-selectin). Lymphology 1999, 32:151-156.